WallStreetZenWallStreetZen

NASDAQ: CRBP
Corbus Pharmaceuticals Holdings Inc Stock Ownership - Who owns Corbus Pharmaceuticals Holdings?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Corbus Pharmaceuticals Holdings Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Cormorant Asset Management LP10% Owner2025-12-1130,029$11.46
$344.01kSell
Yuval CohenChief Executive Officer2025-10-278,973$17.14
$153.80kSell
Yuval CohenChief Executive Officer2025-10-278,973$4.26
$38.22kBuy
Yuval CohenChief Executive Officer2025-10-2418,660$17.01
$317.41kSell
Yuval CohenChief Executive Officer2025-10-2418,660$4.26
$79.49kBuy
Sean F. MoranChief Financial Officer2025-10-2412,981$4.26
$55.30kBuy
Sean F. MoranChief Financial Officer2025-10-2412,981$17.02
$220.94kSell
Anne AltmeyerDirector2025-10-201,060$4.80
$5.09kBuy
Anne AltmeyerDirector2025-10-201,060$20.50
$21.73kSell
Anne AltmeyerDirector2025-05-301,392$7.25
$10.10kSell

1 of 2

CRBP insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when CRBP insiders and whales buy or sell their stock.

CRBP Shareholders

What type of owners hold Corbus Pharmaceuticals Holdings Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Cormorant Asset Management LP26.89%4,719,971$38.47MInsider
Sumner Burstein20.48%3,594,571$29.30MInsider
Knoll Capital Management LP15.67%2,750,000$22.41MInsider
Cormorant Asset Management LP13.53%2,375,000$19.36MInstitution
Mark Tepper12.02%2,110,400$17.20MInsider
Orbimed Advisors LLC6.68%1,172,287$9.55MInstitution
Octagon Capital Advisors LP6.35%1,115,000$9.09MInstitution
David P. Hochman4.66%818,700$6.67MInsider
Vanguard Group Inc3.49%612,030$4.99MInstitution
Prosight Management LP1.96%343,400$2.80MInstitution

1 of 3

CRBP vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
CRBP37.52%62.48%Net SellingNet Selling
CGEN13.31%0.00%
ELTX10.93%64.39%Net BuyingNet Buying
SGMO18.60%9.54%Net SellingNet Selling
BDTX65.77%34.23%Net SellingNet Buying
View Top Biotech Stocks

Corbus Pharmaceuticals Holdings Stock Ownership FAQ

Who owns Corbus Pharmaceuticals Holdings?

Corbus Pharmaceuticals Holdings (NASDAQ: CRBP) is owned by 50.13% institutional shareholders, 83.48% Corbus Pharmaceuticals Holdings insiders, and 0.00% retail investors. Cormorant Asset Management LP is the largest individual Corbus Pharmaceuticals Holdings shareholder, owning 4.72M shares representing 26.89% of the company. Cormorant Asset Management LP's Corbus Pharmaceuticals Holdings shares are currently valued at $38.23M.

If you're new to stock investing, here's how to buy Corbus Pharmaceuticals Holdings stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.